Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice

Biology Open

Volumn 1, Issue 7, 2012, Pages 629-639

  Pandey, Sachchida N ^a   Cabotage, Jennifer ^a   Shi, Rongye ^a   Dixit, Manjusha ^a   Sutherland, Margret ^a,b   Liu, Jian ^c   Muger, Stephanie ^a   Harper, Scott Q ^c,d   Nagaraju, Kanneboyina ^a,b   Chen, Yi Wen ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cell death; D4Z4; Grip strength; Rotarod; Tet off

Indexed keywords

EID: 84964817861     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20121305     Document Type: Article

References (98)

1. Andersen, J. L., Gruschy-Knudsen, T., Sandri, C., Larsson, L. and Schiaffino, S. (1999). Bed rest increases the amount of mismatched fibers in human skeletal muscle. J. Appl. Physiol. 86, 455-460.
2. Arahata, K., Ishihara, T., Fukunaga, H., Orimo, S., Lee, J. H., Goto, K. and Nonaka, I. (1995). Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 18 S13, S56-S66.
3. Aranda-Anzaldo, A., Orozco-Velasco, F., García-Villa, E. and Gariglio, P. (1999). p53 is a rate-limiting factor in the repair of higher-order DNA structure. Biochim. Biophys. Acta 1446, 181-192.
4. Banker, B. Q. (1986). Arthrogryposis multiplex congenita: spectrum of pathologic changes. Hum. Pathol. 17, 656-672.
5. Benedetti, S., Bertini, E., Iannaccone, S., Angelini, C., Trisciani, M., Toniolo, D., Sferrazza, B., Carrera, P., Comi, G., Ferrari, M. et al. (2005). Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 76, 1019-1021.
6. Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J. et al. (2001a). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019.
7. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K. et al. (2001b). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
8. Bosnakovski, D., Daughters, R. S., Xu, Z., Slack, J. M. and Kyba, M. (2009). Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHDrelated repeats. PLoS ONE 4, e7003.
9. Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. and Magyar, J. P. (2004). Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14, 675-682.
10. Brouwer, O. F., Padberg, G. W., Ruys, C. J., Brand, R., de Laat, J. A. and Grote, J. J. (1991). Hearing loss in facioscapulohumeral muscular dystrophy. Neurology 41, 1878-1881.
11. Calvisi, D. F., Ladu, S., Conner, E. A., Seo, D., Hsieh, J. T., Factor, V. M. and Thorgeirsson, S. S. (2011). Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J. Hepatol. 54, 311-319.
12. Castellano, V., Feinberg, J. and Michaels, J. (2008). Facioscapulohumeral dystrophy: case report and discussion. HSS J. 4, 175-179.
13. Castinetti, F., Brinkmeier, M. L., Gordon, D. F., Vella, K. R., Kerr, J. M., Mortensen, A. H., Hollenberg, A., Brue, T., Ridgway, E. C. and Camper, S. A. (2011). PITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism. Mol. Endocrinol. 25, 1950-1960.
14. Chen, Y. W., Zhao, P., Borup, R. and Hoffman, E. P. (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336.
15. Chen, Y., Knösel, T., Ye, F., Pacyna-Gengelbach, M., Deutschmann, N. and Petersen, I. (2007). Decreased PITX1 homeobox gene expression in human lung cancer. Lung Cancer 55, 287-294.
16. Civas, A., Island, M. L., Génin, P., Morin, P. and Navarro, S. (2002). Regulation of virus-induced interferon-A genes. Biochimie 84, 643-654.
17. Clapp, J., Mitchell, L. M., Bolland, D. J., Fantes, J., Corcoran, A. E., Scotting, P. J., Armour, J. A. and Hewitt, J. E. (2007). Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 264-279.
18. Coletti, D., Yang, E., Marazzi, G. and Sassoon, D. (2002). TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21, 631-642.
19. Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A. M., Leo, O. et al. (2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. USA 104, 18157-18162.
20. Emery, A. E. (2002). The muscular dystrophies. Lancet 359, 687-695.
21. Engel, W. K. and Kossman, R. J. (1963). Selective involvement of histochemical type I muscle fibers in a patient with facioscapulohumeral muscular dystrophy. Neurology (Minneapolis) 13, 362.
22. Fenichel, G. M., Emery, E. S. and Hunt, P. (1967). Neurogenic atrophy simulating facioscapulohumeral dystrophy. A dominant form. Arch. Neurol. 17, 257-260.
23. Furukawa, T., Tsukagoshi, H., Sugita, H. and Toyokura, Y. (1969). Neurogenic muscular atrophy simulating facioscapulohumeral muscular dystrophy with particular reference to the heterogeneity of Kugelberg-Welander disease. J. Neurol. Sci. 9, 389-397.
24. Gabellini, D., Green, M. R. and Tupler, R. (2002). Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110, 339-348.
25. Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., Angeletti, B., Ciscato, P., Pellegrino, M. A., Bottinelli, R. et al. (2006). Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439, 973-977.
26. Gabriëls, J., Beckers, M. C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S. M., Padberg, G. W., Frants, R. R., Hewitt, J. E., Collen, D. et al. (1999). Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236, 25-32.
27. Ghersa, P., Gobert, R. P., Sattonnet-Roche, P., Richards, C. A., Merlo Pich, E. and Hooft van Huijsduijnen, R. (1998). Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther. 5, 1213-1220.
28. Gurnett, C. A., Alaee, F., Kruse, L. M., Desruisseau, D. M., Hecht, J. T., Wise, C. A., Bowcock, A. M. and Dobbs, M. B. (2008). Asymmetric lower-limb malformations in individuals with homeobox PITX1 gene mutation. Am. J. Hum. Genet. 83, 616-622.
29. Hudgson, P., Bradley, W. G. and Jenkison, M. (1972). Familial "mitochondrial" myopathy: a myopathy associated with disordered oxidative metabolism in muscle fibres. Part 1. Clinical, electrophysiological and pathological findings. J. Neurol. Sci. 16, 343-370.
30. Jackman, R. W. and Kandarian, S. C. (2004). The molecular basis of skeletal muscle atrophy. Am. J. Physiol. Cell Physiol. 287, C834-C843.
31. Jagoe, R. T., Lecker, S. H., Gomes, M. and Goldberg, A. L. (2002). Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J. 16, 1697-1712.
32. Jiang, G., Yang, F., van Overveld, P. G., Vedanarayanan, V., van der Maarel, S. and Ehrlich, M. (2003). Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum. Mol. Genet. 12, 2909-2921.
33. Kilmer, D. D., Abresch, R. T., McCrory, M. A., Carter, G. T., Fowler, W. M., Jr, Johnson, E. R. and McDonald, C. M. (1995). Profiles of neuromuscular diseases: facioscapulohumeral muscular dystrophy. Am. J. Phys. Med. Rehabil. 74 Suppl, S131-S139.
34. Kioussi, C., Briata, P., Baek, S. H., Rose, D. W., Hamblet, N. S., Herman, T., Ohgi, K. A., Lin, C., Gleiberman, A., Wang, J. et al. (2002). Identification of a Wnt/Dvl/beta-Catenin. Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111, 673-685.
35. Kissel, J. T. (1999). Facioscapulohumeral dystrophy. Semin. Neurol. 19, 35-43.
36. Kolfschoten, I. G., van Leeuwen, B., Berns, K., Mullenders, J., Beijersbergen, R. L., Bernards, R., Voorhoeve, P. M. and Agami, R. (2005). A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 121, 849-858.
37. Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Mattéotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O. et al. (2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord. 17, 611-623.
38. L'Honoré, A., Coulon, V., Marcil, A., Lebel, M., Lafrance-Vanasse, J., Gage, P., Camper, S. and Drouin, J. (2007). Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development. Dev. Biol. 307, 421-433.
39. L'Honoré, A., Ouimette, J.-F., Lavertu-Jolin, M. and Drouin, J. (2010). Pitx2 defines alternate pathways acting through MyoD during limb and somitic myogenesis. Development 137, 3847-3856.
40. Lamba, P., Khivansara, V., D'Alessio, A. C., Santos, M. M. and Bernard, D. J. (2008). Paired-like homeodomain transcription factors 1 and 2 regulate folliclestimulating hormone beta-subunit transcription through a conserved cis-element. Endocrinology 149, 3095-3108.
41. Lamonerie, T., Tremblay, J. J., Lanctôt, C., Therrien, M., Gauthier, Y. and Drouin, J. (1996). Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev. 10, 1284-1295.
42. Lanctôt, C., Moreau, A., Chamberland, M., Tremblay, M. L. and Drouin, J. (1999). Hindlimb patterning and mandible development require the Ptx1 gene. Development 126, 1805-1810.
43. Laoudj-Chenivesse, D., Carnac, G., Bisbal, C., Hugon, G., Bouillot, S., Desnuelle, C., Vassetzky, Y. and Fernandez, A. (2005). Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J. Mol. Med. 83, 216-224.
44. Lemmers, R. J. L. F., van der Vliet, P. J., Klooster, R., Sacconi, S., Camaño, P., Dauwerse, J. G., Snider, L., Straasheijm, K. R., van Ommen, G. J., Padberg, G. W. et al. (2010). A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653.
45. Leucht, P., Kim, J. B., Amasha, R., James, A. W., Girod, S. and Helms, J. A. (2008). Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 135, 2845-2854.
46. Lin, M. Y. and Nonaka, I. (1991). Facioscapulohumeral muscular dystrophy: muscle fiber type analysis with particular reference to small angular fibers. Brain Dev. 13, 331-338.
47. Liu, D. X. and Lobie, P. E. (2007). Transcriptional activation of p53 by Pitx1. Cell Death Differ. 14, 1893-1907.
48. Logan, M. and Tabin, C. J. (1999). Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity. Science 283, 1736-1739.
49. Lunt, P. W. and Harper, P. S. (1991). Genetic counselling in facioscapulohumeral muscular dystrophy. J. Med. Genet. 28, 655-664.
50. Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J. et al. (2007). FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6, 458-471.
51. Marcil, A., Dumontier, E., Chamberland, M., Camper, S. A. and Drouin, J. (2003). Pitx1 and Pitx2 are required for development of hindlimb buds. Development 130, 45-55.
52. Masny, P. S., Bengtsson, U., Chung, S. A., Martin, J. H., van Engelen, B., van der Maarel, S. M. and Winokur, S. T. (2004). Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum. Mol. Genet. 13, 1857-1871.
53. Matecki, S., Guibinga, G. H. and Petrof, B. J. (2004). Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R961-R968.
54. Moresi, V., Pristerà, A., Scicchitano, B. M., Molinaro, M., Teodori, L., Sassoon, D., Adamo, S. and Coletti, D. (2008). Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response. Stem Cells 26, 997-1008.
55. Nakagawa, M., Matsuzaki, T., Higuchi, I., Fukunaga, H., Inui, T., Nagamitsu, S., Yamada, H., Arimura, K. and Osame, M. (1997). Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients. Intern. Med. 36, 333-339.
56. Neudecker, S., Krasnianski, M., Bahn, E. and Zierz, S. (2004). Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature. Acta Neuropathol. 108, 257-259.
57. Olsen, D. B., Gideon, P., Jeppesen, T. D. and Vissing, J. (2006). Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J. Neurol. 253, 1437-1441.
58. Padberg, G. W., Lunt, P. W., Koch, M. and Fardeau, M. (1991). Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 1, 231-234.
59. Padberg, G. W., Frants, R. R., Brouwer, O. F., Wijmenga, C., Bakker, E. and Sandkuijl, L. A. (1995a). Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 18 S13, S81-S84.
60. Padberg, G. W., Brouwer, O. F., de Keizer, R. J., Dijkman, G., Wijmenga, C., Grote, J. J. and Frants, R. R. (1995b). On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve 18 S13, S73-S80.
61. Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M. and Schiaffino, S. (2002). A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA 99, 9213-9218.
62. Porrello, A., Cerone, M. A., Coen, S., Gurtner, A., Fontemaggi, G., Cimino, L., Piaggio, G., Sacchi, A. and Soddu, S. (2000). p53 regulates myogenesis by triggering the differentiation activity of pRb. J. Cell Biol. 151, 1295-1304.
63. Qi, D.-L., Ohhira, T., Fujisaki, C., Inoue, T., Ohta, T., Osaki, M., Ohshiro, E., Seko, T., Aoki, S., Oshimura, M. et al. (2011). Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol. Cell. Biol. 31, 1624-1636.
64. Qureshi, A. R., Alvestrand, A., Danielsson, A., Divino-Filho, J. C., Gutierrez, A., Lindholm, B. and Bergström, J. (1998). Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int. 53, 773-782.
65. Reilich, P., Schramm, N., Schoser, B., Schneiderat, P., Strigl-Pill, N., Müller-Höcker, J., Kress, W., Ferbert, A., Rudnik-Schöneborn, S., Noth, J. et al. (2010). Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy. J. Neurol. 257, 1108-1118.
66. Rinn, J. L., Wang, J. K., Allen, N., Brugmann, S. A., Mikels, A. J., Liu, H., Ridky, T. W., Stadler, H. S., Nusse, R., Helms, J. A. et al. (2008). A dermal HOX transcriptional program regulates site-specific epidermal fate. Genes Dev. 22, 303-307.
67. Sandri, M., El Meslemani, A. H., Sandri, C., Schjerling, P., Vissing, K., Andersen, J. L., Rossini, K., Carraro, U. and Angelini, C. (2001). Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J. Neuropathol. Exp. Neurol. 60, 302-312.
68. Schwarzkopf, M., Coletti, D., Sassoon, D. and Marazzi, G. (2006). Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev. 20, 3440-3452.
69. Shapiro, M. D., Marks, M. E., Peichel, C. L., Blackman, B. K., Nereng, K. S., Jónsson, B., Schluter, D. and Kingsley, D. M. (2004). Genetic and developmental basis of evolutionary pelvic reduction in threespine sticklebacks. Nature 428, 717-723.
70. Shih, H. P., Gross, M. K. and Kioussi, C. (2007). Expression pattern of the homeodomain transcription factor Pitx2 during muscle development. Gene Expr. Patterns 7, 441-451.
71. Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P. et al. (2002). Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209.
72. Slipetz, D. M., Aprille, J. R., Goodyer, P. R. and Rozen, R. (1991). Deficiency of complex III of the mitochondrial respiratory chain in a patient with facioscapulohumeral disease. Am. J. Hum. Genet. 48, 502-510.
73. Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M. G., Bossi, G., Cimino, L., Crescenzi, M. and Sacchi, A. (1996). Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134, 193-204.
74. St Amand, T. R., Zhang, Y., Semina, E. V., Zhao, X., Hu, Y., Nguyen, L., Murray, J. C. and Chen, Y. (2000). Antagonistic signals between BMP4 and FGF8 define the expression of Pitx1 and Pitx2 in mouse tooth-forming anlage. Dev. Biol. 217, 323-332.
75. Subramanian, L., Crabb, J. W., Cox, J., Durussel, I., Walker, T. M., van Ginkel, P. R., Bhattacharya, S., Dellaria, J. M., Palczewski, K. and Polans, A. S. (2004). Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma. Biochemistry 43, 11175-11186.
76. Szeto, D. P., Rodriguez-Esteban, C., Ryan, A. K., O'Connell, S. M., Liu, F., Kioussi, C., Gleiberman, A. S., Izpisúa-Belmonte, J. C. and Rosenfeld, M. G. (1999). Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev. 13, 484-494.
77. Tamir, Y. and Bengal, E. (1998). p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene 17, 347-356.
78. Tawil, R. and Van Der Maarel, S. M. (2006). Facioscapulohumeral muscular dystrophy. Muscle Nerve 34, 1-15.
79. Tawil, R., Figlewicz, D. A., Griggs, R. C. and Weiffenbach, B. (1998). Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann. Neurol. 43, 279-282.
80. Taylor, D. A., Carroll, J. E., Smith, M. E., Johnson, M. O., Johnston, G. P. and Brooke, M. H. (1982). Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome. Ann. Neurol. 12, 395-398.
81. Tisdale, M. J. (1997). Biology of cachexia. J. Natl. Cancer Inst. 89, 1763-1773.
82. Tremblay, J. J., Lanctôt, C. and Drouin, J. (1998). The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol. Endocrinol. 12, 428-441.
83. Tsumagari, K., Chang, S.-C., Lacey, M., Baribault, C., Chittur, S. V., Sowden, J., Tawil, R., Crawford, G. E. and Ehrlich, M. (2011). Gene expression during normal and FSHD myogenesis. BMC Med. Genomics 4, 67.
84. Tyler, F. H. and Stephens, F. E. (1950). Studies in disorders of muscle. II Clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family. Ann. Intern. Med. 32, 640-660.
85. Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C. et al. (2002). p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53.
86. van Deutekom, J. C. T., Wijmenga, C., van Tienhoven, E. A. E., Gruter, A.-M., Hewitt, J. E., Padberg, G. W., van Ommen, G.-J. B., Hofker, M. H. and Frants, R. R. (1993). FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037-2042.
87. van Overveld, P. G., Lemmers, R. J., Sandkuijl, L. A., Enthoven, L., Winokur, S. T., Bakels, F., Padberg, G. W., van Ommen, G. J., Frants, R. R. and van der Maarel, S. M. (2003). Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35, 315-317.
88. Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton, S. D., Coppée, F. and Belayew, A. (2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS ONE 6, e26820.
89. Voit, T., Lamprecht, A., Lenard, H. G. and Goebel, H. H. (1986). Hearing loss in facioscapulohumeral dystrophy. Eur. J. Pediatr. 145, 280-285.
90. Vousden, K. H. (2000). p53: death star. Cell 103, 691-694.
91. Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppee, F., Ladner, K. J., Guttridge, D., Yang, J. and Harper, S. Q. (2011). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol. 69, 540-552.
92. Wegel, E. and Shaw, P. (2005). Gene activation and deactivation related changes in the three-dimensional structure of chromatin. Chromosoma 114, 331-337.
93. Weissman, J. R., Kelley, R. I., Bauman, M. L., Cohen, B. H., Murray, K. F., Mitchell, R. L., Kern, R. L. and Natowicz, M. R. (2008). Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS ONE 3, e3815.
94. Winokur, S. T., Barrett, K., Martin, J. H., Forrester, J. R., Simon, M., Tawil, R., Chung, S. A., Masny, P. S. and Figlewicz, D. A. (2003). Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord. 13, 322-333.
95. Yamaguchi, T., Miki, Y. and Yoshida, K. (2010). The c-Abl tyrosine kinase stabilizes Pitx1 in the apoptotic response to DNA damage. Apoptosis 15, 927-935.
96. Yoshioka, H., Meno, C., Koshiba, K., Sugihara, M., Itoh, H., Ishimaru, Y., Inoue, T., Ohuchi, H., Semina, E. V., Murray, J. C. et al. (1998). Pitx2, a bicoid-type homeobox gene, is involved in a lefty-signaling pathway in determination of left-right asymmetry. Cell 94, 299-305.
97. Zacharias, A. L., Lewandoski, M., Rudnicki, M. A. and Gage, P. J. (2011). Pitx2 is an upstream activator of extraocular myogenesis and survival. Dev. Biol. 349, 395-405.
98. Zeng, W., de Greef, J. C., Chen, Y. Y., Chien, R., Kong, X., Gregson, H. C., Winokur, S. T., Pyle, A., Robertson, K. D., Schmiesing, J. A. et al. (2009). Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet. 5, e1000559.